Nyxoah SA Ordinary Shares

Nyxoah has secured $15 million in non-dilutive debt funding from the European Investment Bank, complementing the company's June equity raise and bringing total capital raised to $110 million. The company is also holding an extraordinary general shareholders' meeting on July 9, 2026, to renew authorization for capital increases.

Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) has announced an extraordinary shareholders' meeting scheduled for July 9, 2026, to vote on renewing the board of directors' authorization to increase the company's share capital. The meeting will allow shareholders to participate in-person or via video conference, with voting available through proxy or ...

Nyxoah SA completed an underwritten public offering of 55.2 million new shares to accelerate the U.S. commercial launch of its Genio product, raising $110 million in aggregate financing. The offering included both public shares in the U.S. and private placements to qualified investors internationally, including the EU.

Nyxoah SA completed an underwritten public offering, issuing 55,232,558 new shares to accelerate the U.S. commercial launch of its Genio product. The company secured $110 million in aggregate financings. Following the offering, the total number of voting rights increased to 99,926,284 ordinary shares.

Nyxoah SA announced that it received a transparency notification on March 19, 2026, regarding Robert Taub and Robelga SRL crossing above the 3% threshold on December 30, 2025. The combined holding represents 10.14% of total voting rights (4,360,800 voting rights out of 43,026,460), consisting of 4,310,800 voting rights linked to securities and 50...